Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease

被引：0
|
作者：
Gao, Xiaoya [1 ,2 ]
机构：
[1] Southern Med Univ, Zhujiang Hosp, Dept Pediat Neurol, Guangzhou, Guangdong, Peoples R China
[2] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China
来源：
FRONTIERS IN AGING NEUROSCIENCE | 2023年 / 15卷
关键词：
Alzheimer's disease; Parkinson's disease; disease modification; neuroprotection; novel targets; neurodegeneration;
D O I：
10.3389/fnagi.2023.1247256
中图分类号：
R592 [老年病学]; C [社会科学总论];
学科分类号：
03 ; 0303 ; 100203 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [31] Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
    Ettcheto, Miren
    Busquets, Oriol
    Camins, Antoni
    NEURAL REGENERATION RESEARCH, 2019, 14 (10) : 1721 - 1725
  • [32] New Avenues for Parkinson's Disease Therapeutics: Disease-Modifying Strategies Based on the Gut Microbiota
    Lorente-Picon, Marina
    Laguna, Ariadna
    BIOMOLECULES, 2021, 11 (03) : 1 - 39
  • [33] Potential preventive disease-modifying pharmacological strategies to delay late onset Alzheimer's disease
    Miren Ettcheto
    Oriol Busquets
    Antoni Camins
    Neural Regeneration Research, 2019, 14 (10) : 1721 - 1725
  • [34] Clinical Management in Alzheimer's Disease in the Era of Disease-Modifying Therapies
    Guo, Michael H.
    Vaishnavi, Sanjeev N.
    CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2023, 25 (05) : 121 - 133
  • [35] Protease inhibitors as potential disease-modifying therapeutics for Alzheimer's disease
    Beher, D
    Graham, SL
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2005, 14 (11) : 1385 - 1409
  • [36] Therapeutic news in Alzheimer's disease: soon a disease-modifying therapy?
    Villain, Nicolas
    GERIATRIE ET PSYCHOLOGIE NEUROPSYCHIATRIE DE VIEILLISSEMENT, 2022, 20 (02): : 256 - 260
  • [37] Therapeutic news in Alzheimer?s disease: Soon a disease-modifying therapy?
    Villain, N.
    REVUE NEUROLOGIQUE, 2022, 178 (05) : 437 - 440
  • [38] Challenges in demonstrating the value of disease-modifying therapies for Alzheimer's disease
    Gustavsson, Anders
    Pemberton-Ross, Peter
    Montero, Melissa Gomez
    Hashim, Mahmoud
    Thompson, Robin
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2020, 20 (06) : 563 - 570
  • [39] Clinical Management in Alzheimer’s Disease in the Era of Disease-Modifying Therapies
    Michael H. Guo
    Sanjeev N. Vaishnavi
    Current Treatment Options in Neurology, 2023, 25 : 121 - 133
  • [40] α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's disease
    Cole, Tracy A.
    Zhao, Hien
    Collier, Timothy J.
    Sandoval, Ivette
    Sortwell, Caryl E.
    Steece-Collier, Kathy
    Daley, Brian F.
    Booms, Alix
    Lipton, Jack
    Welch, Mackenzie
    Berman, Melissa
    Jandreski, Luke
    Graham, Danielle
    Weihofen, Andreas
    Celano, Stephanie
    Schulz, Emily
    Cole-Strauss, Allyson
    Luna, Esteban
    Quach, Duc
    Mohan, Apoorva
    Bennett, C. Frank
    Swayze, Eric E.
    Kordasiewicz, Holly B.
    Luk, Kelvin C.
    Paumier, Katrina L.
    JCI INSIGHT, 2021, 6 (05)
12345